Chemo fog : cancer chemotherapy-related cognitive impairment / edited by Robert B. Raffa, Ronald J. Tallarida.
"Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. Due to the advances in chemotherapy and other aspects of prevention, early detection, and...
Saved in:
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | Ebook |
Language: | English |
Published: |
New York, N.Y. : Austin, Tex. :
Springer Science+Business Media ; Landes Bioscience,
c2010.
|
Series: | Advances in experimental medicine and biology ;
v. 678. |
Subjects: | |
Online Access: | Springer eBooks |
Summary: | "Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. Due to the advances in chemotherapy and other aspects of prevention, early detection, and treatment modalities, an increasing percentage of patients are surviving the disease. For some types of cancer, the majority of patients live decades beyond their diagnosis. For this they are forever thankful and appreciative of the drugs that helped lead to this increased survival rate. But no drug is devoid of adverse effects. This also applies to chemotherapeutic agents. The acute cytotoxic effects of these agents are well known––indeed are often required for their therapeutic benefit. The chronic adverse effects are varied and in some cases less well known. With the increase in survival rates, there has emerged a new awareness of these chronic adverse effects."--Publisher's website. |
---|---|
Item Description: | Description based on print version record. |
Physical Description: | 1 electronic document. |
Format: | Mode of access: World Wide Web. |
Bibliography: | Includes bibliographical references and index. |
ISBN: | 1283074427 1441963065 9781283074421 9781441963062 |